SANTA BARBARA, Calif.--(BUSINESS WIRE)--Dec. 6, 2005--Inamed Corporation (Nasdaq:IMDC) announced today that its Board of Directors determined that the terms of a revised offer and merger agreement received by Inamed from Allergan, Inc. (NYSE:AGN) are fair to the Inamed stockholders and constitute a Company Superior Proposal when compared to the terms of the currently pending merger with Medicis Pharmaceutical Corporation.
